<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Renganathan S</submitter><funding>National Research Foundation of Korea</funding><pagination>5870</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8616359</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(22)</volume><pubmed_abstract>Family with sequence similarity 72 A (FAM72A) is a pivotal mitosis-promoting factor that is highly expressed in various types of cancer. FAM72A interacts with the uracil-DNA glycosylase UNG2 to prevent mutagenesis by eliminating uracil from DNA molecules through cleaving the N-glycosylic bond and initiating the base excision repair pathway, thus maintaining genome integrity. In the present study, we determined a specific FAM72A-UNG2 heterodimer protein interaction using molecular docking and dynamics. In addition, through in silico screening, we identified withaferin B as a molecule that can specifically prevent the FAM72A-UNG2 interaction by blocking its cell signaling pathways. Our results provide an excellent basis for possible therapeutic approaches in the clinical treatment of cancer.</pubmed_abstract><journal>Cancers</journal><pubmed_title>Identification of a Chemotherapeutic Lead Molecule for the Potential Disruption of the FAM72A-UNG2 Interaction to Interfere with Genome Stability, Centromere Formation, and Genome Editing.</pubmed_title><pmcid>PMC8616359</pmcid><funding_grant_id>2019R1F1A1056445</funding_grant_id><pubmed_authors>Kim PS</pubmed_authors><pubmed_authors>Renganathan S</pubmed_authors><pubmed_authors>Kutzner A</pubmed_authors><pubmed_authors>Heese K</pubmed_authors><pubmed_authors>Pramanik S</pubmed_authors><pubmed_authors>Ekambaram R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of a Chemotherapeutic Lead Molecule for the Potential Disruption of the FAM72A-UNG2 Interaction to Interfere with Genome Stability, Centromere Formation, and Genome Editing.</name><description>Family with sequence similarity 72 A (FAM72A) is a pivotal mitosis-promoting factor that is highly expressed in various types of cancer. FAM72A interacts with the uracil-DNA glycosylase UNG2 to prevent mutagenesis by eliminating uracil from DNA molecules through cleaving the N-glycosylic bond and initiating the base excision repair pathway, thus maintaining genome integrity. In the present study, we determined a specific FAM72A-UNG2 heterodimer protein interaction using molecular docking and dynamics. In addition, through in silico screening, we identified withaferin B as a molecule that can specifically prevent the FAM72A-UNG2 interaction by blocking its cell signaling pathways. Our results provide an excellent basis for possible therapeutic approaches in the clinical treatment of cancer.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2024-11-21T07:06:38.444Z</modification><creation>2022-02-11T13:22:53.472Z</creation></dates><accession>S-EPMC8616359</accession><cross_references><pubmed>34831023</pubmed><doi>10.3390/cancers13225870</doi></cross_references></HashMap>